Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jefferies Financial Group
JEF
|
+$460M |
| 2 |
Palo Alto Networks
PANW
|
+$363M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$330M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$291M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$755M |
| 2 |
Microsoft
MSFT
|
+$674M |
| 3 |
Apple
AAPL
|
+$642M |
| 4 |
Flutter Entertainment
FLUT
|
+$572M |
| 5 |
NVIDIA
NVDA
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.47% |
| 4 | Healthcare | 4.72% |
| 5 | Communication Services | 4.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4526
Heron Therapeutics
HRTX
$92.3M
| $139K | ﹤0.01% |
91,014
+5,031
| +6% | +$8.15K |
|
|
FSP
4527
Franklin Street Properties
FSP
$49.5M
| $139K | ﹤0.01% |
75,849
+4,363
| +6% | +$7.97K |
|
4528
Cardiff Oncology
CRDF
$61M
| $139K | ﹤0.01% |
31,972
+3,485
| +12% | +$10.9K |
|
4529
Nomura Holdings
NMR
$28.2B
| $139K | ﹤0.01% |
23,961
-4,295
| -15% | -$24.4K |
|
4530
Prime Medicine
PRME
$535M
| $138K | ﹤0.01% |
47,431
-640
| -1% | -$2.25K |
|
4531
Acumen Pharmaceuticals
ABOS
$157M
| $138K | ﹤0.01% |
80,345
+49,753
| +163% | +$120K |
|
4532
Larimar Therapeutics
LRMR
$383M
| $138K | ﹤0.01% |
35,675
+5,319
| +18% | +$35.1K |
|
4533
Butterfly Network
BFLY
$1.86B
| $138K | ﹤0.01% |
44,248
-462,494
| -91% | -$1.2M |
|
4534
CALL
Capricor Therapeutics
CAPR
$380M
| $138K | ﹤0.01% |
+10,000
| New | +$175K |
|
4535
Reservoir Media
RSVR
$726M
| $138K | ﹤0.01% |
15,235
+263
| +2% | +$2.32K |
|
4536
Zentalis Pharmaceuticals
ZNTL
$325M
| $138K | ﹤0.01% |
45,501
+1,815
| +4% | +$5.95K |
|
|
PVBC
4537
DELISTED
Provident Bancorp
PVBC
| $138K | ﹤0.01% |
12,084
+670
| +6% | +$7.41K |
|
4538
Medallion Financial
MFIN
$227M
| $138K | ﹤0.01% |
14,657
+611
| +4% | +$5.69K |
|
4539
Virginia National Bankshares
VABK
$248M
| $138K | ﹤0.01% |
3,602
+199
| +6% | +$8.13K |
|
4540
iShares Core 10+ Year USD Bond ETF
ILTB
$600M
| $137K | ﹤0.01% |
2,825
-302
| -10% | -$15.3K |
|
|
ONTF
4541
DELISTED
ON24
ONTF
| $137K | ﹤0.01% |
21,255
+1,167
| +6% | +$7.49K |
|
4542
W&T Offshore
WTI
$519M
| $137K | ﹤0.01% |
82,678
+9,897
| +14% | +$19.8K |
|
4543
VanEck Digital Transformation ETF
DAPP
$220M
| $137K | ﹤0.01% |
+9,502
| New | +$148K |
|
|
GRDN
4544
Guardian Pharmacy Services
GRDN
$2.65B
| $136K | ﹤0.01% |
+6,737
| New | +$139K |
|
4545
Dimensional Global Real Estate ETF
DFGR
$3.89B
| $136K | ﹤0.01% |
5,319
+3,009
| +130% | +$82.6K |
|
4546
Lifecore Biomedical
LFCR
$160M
| $136K | ﹤0.01% |
18,276
+962
| +6% | +$6.14K |
|
|
KG
4547
Kestrel Group
KG
$66.3M
| $135K | ﹤0.01% |
4,004
+773
| +24% | +$24.7K |
|
4548
iShares US Healthcare Providers ETF
IHF
$1.23B
| $135K | ﹤0.01% |
2,816
| – | – |
|
4549
CVRx
CVRX
$133M
| $135K | ﹤0.01% |
10,648
+1,051
| +11% | +$13K |
|
4550
Dimensional Emerging Markets Value ETF
DFEV
$1.86B
| $134K | ﹤0.01% |
5,129
+2,944
| +135% | +$80.7K |
|
Similar funds
Citigroup's Q4 2024 Portfolio in Review
As of Q4 2024, Citigroup held 6,077 positions worth $169B, down 2.4% from $173B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup withdrew a net $7.85B in Q4 2024, closing 263 positions and reducing 1,533 holdings. Its most notable exit was Stericycle Inc, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Citigroup opened a new position in T-Rex 2X Long MSTR Daily Target ETF worth $19M.
- Citigroup's largest Q4 2024 buy was T-Rex 2X Long MSTR Daily Target ETF: 249,467 shares worth $19M.
- Citigroup added most to Jefferies Financial Group in Q4 2024, an estimated $460M increase.
- Citigroup's biggest Q4 2024 reduction was Caterpillar, cutting an estimated $755M.
- Citigroup fully exited Stericycle Inc in Q4 2024, selling an estimated $125M.
- Citigroup's ten largest holdings make up 21% of its $169B portfolio in Q4 2024.
- Citigroup opened 429 new positions and closed 263 in Q4 2024.
- Citigroup's portfolio value fell 2.4% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.